4,6-DIAMINOSUBSTITUTED-2-(OXY OR AMINOXY)-(1,3,5)TRIAZINES AS PROTEIN TYROSINE KINASE INHIBITORS
Details for Australian Patent Application No. 2003272740 (hide)
International Classifications
Event Publications
22 January 2004 Complete Application Filed
Priority application(s): 60/414,636 01.10.02 US
27 May 2004 Application Open to Public Inspection
Published as AU-A-2003272740
29 September 2005 Amendment Made
The nature of the amendment is: Amend the name of the applicant/patentee from Johnson & Johnson Pharmaceutical Research & Development, Inc. to Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
25 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003272741-APPARATUS AND METHOD FOR GENERATION OF CHLORINE DIOXIDE GAS
2003272739-SYSTEM, METHOD AND COLLIMATOR FOR OBLIQUE DEPOSITION
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser